Analysis of the results on graphs documented the existence of a significant synergism between BCR-ABL1 and PI3K/Akt/mTOR inhibitors in ALL-SIL and PEER cells as shown in Figure 4A and 4B. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.